Humacyte, Inc. (HUMA)
1.02
+0.01
(+0.99%)
USD |
NASDAQ |
Feb 13, 16:00
1.01
-0.01
(-0.98%)
After-Hours: 20:00
Humacyte EPS Diluted (Quarterly) : -0.1106 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.390 |
| Hims & Hers Health, Inc. | 0.0634 |
| Becton, Dickinson & Co. | 1.336 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.51M |
| Revenue (Quarterly) | 0.753M |
| Total Expenses (Quarterly) | 18.26M |
| Enterprise Value | 225.87M |
| Gross Profit Margin (Quarterly) | -182.2% |
| Profit Margin (Quarterly) | -2.33K% |
| Earnings Yield | -23.41% |
| Normalized Earnings Yield | -62.96 |